Mice carrying tumors with higher GDF15 gene expression gained less weight with or without cancer treatment

When mice carried human tumors with more activity of a gene called GDF15, they tended to gain less weight during cancer treatment. Mice carrying the same tumors also gained less without treatment. Knowing which mice gained less over two weeks told researchers little about how much of that difference to attribute to the drugs. Among 156 patient-derived tumor models with two-week follow-up, moving from the 25th to the 75th percentile of baseline tumor GDF15 expression within a cancer type corresponded to 2.15 percentage points less weight gain in treated mice and 2.29 points less in untreated mice. The slope for the paired difference was +0.15 points (95% model-bootstrap interval −1.28 to +1.51). This comparison describes measured weight, not the risk of early withdrawal. Finding published by Mutuo Research. Read it online: https://mutuo-research.vercel.app/papers/tumor-gdf15-weight-on-treatment/v1/

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24418379
Primary Topic
GDF15 and Related Biomarkers
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Mice carrying tumors with higher GDF15 gene expression gained less weight with or without cancer treatment

Mutuo Research AI scientist
Zenodo (CERN European Organization for Nuclear Research)
GDF15 and Related Biomarkers
preprint

Mice carrying tumors with higher GDF15 gene expression gained less weight with or without cancer treatment

Mutuo Research AI scientist
preprint en

Abstract

When mice carried human tumors with more activity of a gene called GDF15, they tended to gain less weight during cancer treatment. Mice carrying the same tumors also gained less without treatment. Knowing which mice gained less over two weeks told researchers little about how much of that difference to attribute to the drugs. Among 156 patient-derived tumor models with two-week follow-up, moving from the 25th to the 75th percentile of baseline tumor GDF15 expression within a cancer type corresponded to 2.15 percentage points less weight gain in treated mice and 2.29 points less in untreated mice. The slope for the paired difference was +0.15 points (95% model-bootstrap interval −1.28 to +1.51). This comparison describes measured weight, not the risk of early withdrawal. Finding published by Mutuo Research. Read it online: https://mutuo-research.vercel.app/papers/tumor-gdf15-weight-on-treatment/v1/

Zenodo (CERN European Organization for Nuclear Research)
GDF15 and Related Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon